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Abstract
Objective: To examine differences in somatosensory phenotypes of patients with positive and negative neurodynamic tests and compare these
with healthy participants.
Design: Case-control study.
Setting: University department.
Participants: Patients with electrodiagnostically confirmed carpal tunnel syndrome (CTS) (nZ53) and people without CTS (nZ26) participated
in this study (NZ79). Patients with CTS were subgrouped according to the results of the upper limb neurodynamic tests biasing the median nerve
into patients with positive or negative neurodynamic tests.
Interventions: Not applicable.
Main Outcome Measure: All participants underwent quantitative sensory testing in the median innervated territory of their hand.
Results: Only 46% of patients with CTS had positive neurodynamic tests. No differences were identified between groups for pain thresholds
(P>.247). However, patients with CTS had increased mechanical (P<.0001) and thermal detection thresholds (P<.0001) compared with people
without CTS. Patients with negative neurodynamic tests had a more pronounced vibration detection deficit (mean, 7.430.59) than people without
CTS (mean, 7.890.22; PZ.001). Interestingly, warm detection was the only domain differentiating positive (mean, 4.03C2.18C) and
negative neurodynamic test groups (6.09C3.70C, PZ.032), with patients with negative neurodynamic tests demonstrating increased loss
of function.
Conclusions: Patients with negative neurodynamic tests seem to have a more severe dysfunction of the unmyelinated fiber population. Our
findings suggest that neurodynamic tests should not be used in isolation to judge neural involvement. Rather, they should be interpreted in the
context of loss of function tests of the small fiber domain.
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http://dx.doi.org/10.1016/j.apmr.2016.06.019neural structures.1 Commonly used tests include the straight leg
raise or slump test for patients with radiating back or leg pain2 or
upper limb neurodynamic tests (ULNTs) for patients with radiating
neck or arm pain.3,4 The clinometric properties of these tests are
however weak,5-8 which is reflected in a subgroup of patients with
normative neurodynamic tests despite a clear injury to their
peripheral nervous system. For instance, some patients with lumbar
radiculopathy have an inconspicuous straight leg raise,9 and a
substantial proportion of patients with carpal tunnel syndromeublished by Elsevier Inc. This is an open access article under the CC BY
Neurodynamic tests and neural dysfunction 481(CTS) have negative ULNTs despite confirmed nerve involve-
ment.6,10 The question arises why this discrepancy exists and
whether there might be a physiological explanation for the presence
of negative neurodynamic tests despite neural tissue compromise.
Whereas a potential compromise in neural function (loss of
function) is commonly tested with neurologic integrity tests
(sensation, muscle strength, and reflexes), neurodynamic tests
have been proposed to identify alterations of mechanosensitivity
in neural tissue,1,11,12 thus testing gain of function. It is therefore
commonly accepted that minor nerve injuries can present with
positive neurodynamic tests, even if neurologic integrity tests are
normative.13 Given that neurodynamic tests are thought to identify
gain of function (ie, heightened mechanosensitivity), we hypoth-
esize that patients with positive neurodynamic tests are charac-
terized by gain of function, whereas loss of function may prevail
in those with negative neurodynamic tests.
Quantitative sensory testing (QST) is a well-established
method that allows detailed evaluation of somatosensory pheno-
types, including gain and loss of function within small and large
fiber domains. Whereas some studies have used QST in patient
populations with positive neurodynamic tests (eg, radiculopathy,
nonspecific neck or arm pain14,15), to our knowledge, no study has
investigated whether the somatosensory phenotypes differ
between patients with positive and negative neurodynamic tests.
We therefore used QST to examine potential differences in
somatosensory phenotypes of patients with electrodiagnostically
proven CTS, who have either positive or negative neurodynamic
tests, and compare their phenotypes with people without CTS.Methods
Design
This study uses a cross-sectional design and includes data from the
Oxford CTS cohort from May 2013 until August 2015. Data on a
subgroup of this cohort have previously been published.16
Participants
Fifty-three patients who met electrodiagnostic17 and clinical18
criteria for CTS were enrolled in the study. Patients were
recruited through Oxford University Hospitals, local print media,
and public notice boards. Patients were excluded if electro-
diagnostic findings were indicative of other peripheral neuropa-
thies (eg, cubital tunnel syndrome), if another medical condition
affecting the upper extremity or neck was present (eg, tennis
elbow), if a previous history of surgery or trauma to the upper limb
or neck existed, or if CTS was caused by pregnancy or diabetes.
In addition, 26 volunteers without CTS, who were propor-
tionally matched to patients with CTS according to age and sex
and who had no indication of peripheral neuropathies (normative
electrodiagnostic and clinical examination) or previous surgery on
the upper limb or neck, were included. The study was approved by
the local ethics committee, and all participants gave informed
written consent prior to participating.List of abbreviations:
CTS carpal tunnel syndrome
QST quantitative sensory testing
ULNT upper limb neurodynamic test
www.archives-pmr.orgSubgroups
The cohort was divided in 3 subgroups: participants without CTS,
patients with CTS with positive neurodynamic tests biasing the
median nerve (ULNTs 1 and/or 2a),1 and patients with CTS with
negative ULNTs 1 and 2a. Because clinically the test outcomes of
ULNTs 1 and 2a are not necessarily mutually inclusive in patients
with CTS, both tests were included to assure the identification of
any mechanosensitivity of the median nerve. The ULNTs were
performed by a single experienced musculoskeletal physiothera-
pist in a standardized way.19 Patients were positioned in a supine
position with the hand of the untested side resting on the partic-
ipant’s abdomen. The ULNT 1 sequence involved shoulder girdle
fixation, shoulder abduction, wrist extension, supination, shoulder
external rotation, followed by elbow extension. The ULNT 2a
included shoulder girdle depression, elbow extension, shoulder
external rotation, supination and wrist extension, followed by
shoulder abduction. All components were performed to the end of
range or until symptoms were provoked. Patients were instructed
to report the onset of any sensations (eg, stretch, tingling or pain
anywhere in the upper quadrant or neck). ULNTs were rated as
positive if the patients’ current symptoms could be at least
partially reproduced and if a structural differentiation (sensitizing
movements at a site distant to the symptoms) was indicative of
neural involvement1,19 (eg, shoulder elevation relieves finger
symptoms during ULNT 2a). This standardized performance is in
accordance with recommended criteria for the execution and
interpretation of ULNTs20 and has shown moderate intertester
reliability.19 Participants were familiarized with this test procedure
on the nonexperimental arm before testing the experimental side.
Questionnaires
All participants completed the Pain Anxiety Symptom Scale21 and
the Pain Catastrophizing Scale rumination, magnification, and
helplessness subscales22 to examine a potential difference in
psychological factors between the 3 groups. Patients with CTS
also completed the Boston Carpal Tunnel Questionnaire,23 the
Neuropathic Pain Symptom Inventory,24 and the Leeds Assess-
ment of Neuropathic Symptoms Scale.25
Quantitative Sensory Testing
QST was performed according to the standardized protocol of the
German Research Network on Neuropathic Pain by a trained
investigator.26 This protocol is designed to comprehensively
examine loss and gain of function in different fiber domains,
including thick myelinated, thin myelinated, and unmyelinated
fibers. For thermal testing, a Thermotesta (thermode size:
2550mm) was used to measure the cold detection threshold and
warm detection threshold and the cold pain threshold and heat
pain threshold. We also recorded paradoxical heat sensations
during thermal sensory limen testing. The mechanical detection
threshold was measured with Von Frey hairs,b and the mechanical
pain threshold was measured with weighted PinPrick stimulators.c
The pressure pain threshold was determined with a manual
algometer,d and the vibration detection threshold was determined
with a Rydel Seiffer tuning fork.e Mechanical pain sensitivity was
determined with a numerical pain rating scale (0e100) during
5 sets of 7 pseudorandom pin-prick stimulations. Intermingled
with these pin-prick stimulations were 5 sets of 3 light-touch
stimulations with a cotton wisp, a cotton wool tip, and a
482 L.T. Baselgia et alstandardized brush (Sense-laba). The wind up ratio was deter-
mined as the mean numerical pain rating of 5 trains of 10
pin-prick stimulations divided by the mean rating of 5 single
stimuli. More details on this standardized QST protocol and the
exact calculation of the values can be found elsewhere.27
All subjects were familiarized with the QST procedure on the
dorsum of the hand before the actual measurements started. QST
data were collected in the median nerve territory on the palmar
side of the index finger. The pressure pain threshold was recorded
over the thenar eminence, and the vibration detection threshold
was tested over the palmar side of the distal end of the second
metacarpal. In patients, the more affected hand was taken as the
test site. Because QST parameters do not differ between sides, we
standardized the QST measurements to the nondominant hand in
those without CTS.27 To achieve normally distributed data, all
QST parameters except for the cold and heat pain thresholds and
vibration detection thresholds were log-transformed28,29 and
expressed as z scores.27 A small constant of 0.1 was added to the
mechanical pain sensitivity to avoid loss of zero rating values.26
To allow group comparison, z scores were calculated as
zZ(value of the participantmean value of healthy controls)/SD
of healthy controls. Positive z scores therefore represent gain of
function, whereas negative values indicate loss of function.27Statistical analysis
IBM SPSS Statistics 22f was used for statistical analysis. The z
scores of the QST data and the scores from the Pain Catastroph-
izing Scale, Pain Anxiety Symptom Scale, and Depression,
Anxiety and Positive Outlook Scale were compared among the 3
groups with 1-way analyses of variance followed by Tukey post
hoc analysis. The Boston questionnaire, Neuropathic Pain
Symptom Inventory, and Leeds Assessment of Neuropathic
Symptoms Scale were compared among the 2 groups of patients
with CTS using independent t tests. Sample size calculation based
on previously published data of our cohort16 revealed that at least
24 participants are needed per group to identify significant dif-
ferences in detection thresholds among groups with 80% power
and significance set at PZ.05 (effect sizes, .36<Cohen’s f>.56).g
This sample size also allows the detection of a 20% difference in
pressure pain thresholds between groups, which is more sensitive
than the reported clinically relevant difference of 36%.27Results
Demographic variables and questionnaires
The study overall included 79 participants: people without CTS
(nZ26, 18 women), patients with CTS with negative ULNTs
(nZ29, 14 women), and patients with CTS with positive ULNTs
(nZ24, 18 women). Within the positive ULNT subgroup, 41.6%
of patients had both positive ULNT 1 and 2a (nZ10), 37.5% had
only a positive ULNT 2a (nZ9), and 20.8% had only a positive
ULNT 1 (nZ5).
Age (PZ.134), height (PZ.105), weight (PZ.071), and sex
distributions (PZ.176) were comparable between groups (table 1).
For psychological variables, no differences were detected between
groups for all scales (P>.08) except for the Pain Anxiety Symptom
Scale and Depression and the positive outlook subscale of the
Anxiety and Positive Outlook Scale, in which patients with CTSwere significantly different from participants without CTS inde-
pendent of the ULNT subgroup (P<.029) (see table 1). The dura-
tion of symptoms in the patient groups (PZ.311), the
electrodiagnostic severity graded with the Bland scale (PZ.954),30
the scores of the Boston questionnaire for both symptoms and
function (P>.358), and the measures of neuropathic pain (Neuro-
pathic Pain Symptom Inventory: PZ.904, Leeds Assessment of
Neuropathic Symptoms Scale: PZ.726) were comparable between
the positive and negative ULNT groups (see table 1).
Somatosensory phenotype
For detection thresholds, we found a significant difference
between groups for the cold and warm detection thresholds and
thermal sensory limen testing (all P<.0001) and the vibration and
mechanical detection thresholds (PZ.001 and P<.0001 respec-
tively) (table 2 and fig 1A). Post hoc analysis demonstrated that
both the positive and negative ULNT groups had significantly
more loss of function in the cold and warm detection thresholds,
sensory limen testing, and mechanical detection threshold than
participants without CTS (all P<.047). For the vibration detection
thresholds, patients with negative ULNTs had a reduced vibration
detection sense compared with participants without CTS
(PZ.001), but no differences were found between participants
without CTS and patients with positive ULNTs (PZ.193) or be-
tween patient groups (PZ.119). The only significant difference
between the negative and positive ULNT groups was for the warm
detection thresholds (PZ.032), which revealed a more pro-
nounced deficit in patients with negative ULNTs, indicating
increased loss of unmyelinated fiber function.
We did not identify any significant differences between
groups for all pain thresholds (cold, heat, mechanical, and
pressure pain thresholds all P>.247) (fig 1B) and mechanical
pain sensitivity (PZ.697). One patient in each ULNT group
presented with a paradoxical heat sensation, whereas no partic-
ipant had a dynamic mechanical allodynia.Discussion
The findings of this study suggest that >54% of patients with CTS
have negative neurodynamic tests despite a clear median nerve
dysfunction as proven with electrodiagnostic tests. Interestingly,
patients with negative ULNTs have a somatosensory phenotype,
indicating a more pronounced impairment of warm detection
sense than patients with positive ULNTs. Our findings suggest that
neurodynamic tests in isolation are not sufficient to determine
neural involvement. Indeed, patients with negative ULNTs seem
to have a more pronounced dysfunction of the small unmyelinated
nerve fiber population than patients with positive ULNTs.
Our finding that a significant proportion of patients with proven
nerve involvement have negative neurodynamic tests is in line with
previous studies. For instance, approximately 58% of patients with
lumbosacral radiculopathy have a negative straight leg raise,8 and
for CTS, the percentage of positive ULNTs varies from 18% to
72%.5-7 This variation in prevalence values among the different
studies is most likely explained by the different performances of
ULNTs and the varying criteria for a positive test. For instance,
some studies used structural differentiation as an essential criterion
to rate a neurodynamic test as positive,5 whereas structural differ-
entiation was not required for a positive test outcome in other
studies.7 We strictly adhered to the recommended criteria for awww.archives-pmr.org
Table 1 Demographic and clinical variables of included participants
Variable ULNTpos Group ULNTneg Group Participants Without CTS P
Age (y) 54.113.9 59.213.9 51.017.3 .134
Sex (f/m) 18/6 14/15 18/8 .176
Height (cm) 163.511.6 169.610.9 168.49.9 .105
Weight (kg) 73.811.5 81.418.9 72.115.3 .071
BMI (kg/m2) 27.17.5 27.87.6 24.56.1 .193
Symptom duration (m) 55.068.1 76.181.9 .311
PCS 9.510.0 14.112.3 7.98.9 .080
DAPOS
Depression 6.233.34 7.004.50 6.772.93 .746
Anxiety 4.082.84 4.382.77 3.731.22 .608
Outlook 9.734.77* 9.764.62* 12.382.26 .029
PASS 21.518.8* 19.617.7* 8.411.6 .011
EDT grade .954
Very mild 3 5
Mild 6 6
Moderate 8 9
Severe 4 5
Very severe 3 4
Boston questionnaire
Symptoms 2.600.7 2.710.6 .544
Function 1.980.6 2.170.82 .358
NPSI 4.98.2 4.64 7.7 .904
s-LANSS 8.885.97 8.286.30 .726
NOTE. Values are mean  SD or as otherwise indicated.
Abbreviations: BMI, body mass index; DAPOS, Depression, Anxiety and Positive Outlook Scale; EDT, electrodiagnostic tests; f, female; m, male; NPSI,
Neuropathic Pain Symptom Inventory; PASS, Pain Anxiety Symptoms Scale; PCS, Pain Catastrophizing Scale; s-LANSS, self-version of the Leeds
Assessment of Neuropathic Symptoms Scale; ULNTneg, negative upper limb neurodynamic test; ULNTpos, positive upper limb neurodynamic tests.
* Indicates statistically significant differences compared to participants without CTS.
Neurodynamic tests and neural dysfunction 483standardized performance and interpretation of ULNTs,20 which
includes structural differentiation as an essential test criterion.
Not surprisingly, both ULNTs biasing the median nerve were
positive only in approximately 42% of our patients. Originally, theTable 2 QST parameters
QST Parameter ULNTpos Group ULNT
CDT (deg Celsius) 4.012.64* 4.
WDT (deg Celsius) 4.032.18* 6.
TSL (deg Celsius) 8.896.56* 10.
MDT (mN) 7.6718.59* 3.
VDT (/8) 7.670.40 7.
CPT (deg Celsius) 9.896.42 9.
HPT (deg Celsius) 43.353.53 44.
MPT (mN) 166.44111.61 162.
MPS (rating 0e100) 0.680.85 2.
WUR 2.431.96 2.
PPT (kPa) 330.17125.23 375.
NOTE. Data are presented as mean  SD for untransformed data (CPT, HPT, and
statistics done on z scores.
Abbreviations: ANOVA, analysis of variance; CDT, cold detection threshold;
detection threshold; MPS, mechanical pain sensitivity; MPT, mechanical pain t
TSL, thermal sensory limen; ULNTneg, negative upper limb neurodynamic test; U
threshold; WDT, warm detection threshold; WUR, wind up ratio.
* Significant difference compared with participants without CTS.
y Significant difference compared with the ULNTpos group.
www.archives-pmr.orgULNT 1 was developed to increase the strain on the brachial
plexus,3 whereas ULNT 2a includes a prolonged period of strain
on the distal median nerve. This may explain why positive neu-
rodynamic tests were more prevalent for the ULNT 2a than theneg Group
Participants
Without CTS P (ANOVA)
293.26* 2.170.92 <.0001
093.70*,y 2.841.53 <.0001
076.08* 5.132.72 <.0001
418.78* 0.360.25 <.0001
430.59* 7.890.22 .001
416.57 10.027.18 .954
444.17 43.463.84 .526
46112.18 150.8779.72 .994
006.29 0.710.71 .697
171.19 2.101.15 .925
40118.26 347.1982.28 .247
VDT), retransformed mean for log-transformed data. The P values reflect
CPT, cold pain threshold; HPT, heat pain threshold; MDT, mechanical
hreshold; PPT, pressure pain threshold; QST, quantitative sensory testing;
LNTpos, positive upper limb neurodynamic tests; VDT, vibration detection
Fig 1 Somatosensory phenotype. The mean z score sensory profiles are shown of participants without CTS (green), patients with ULNTpos (red),
and patients with ULNTneg (orange). (A) QST domains reflecting detection thresholds. (B) Pain thresholds. )Significance compared with par-
ticipants without CTS. #Significance between CTS groups. Error bars represent SDs. Abbreviations: TSL, thermal sensory limen; ULNTneg, negative
neurodynamic tests; ULNTpos, positive neurodynamic tests; WUR, wind up ratio.
484 L.T. Baselgia et alULNT 1. Following the principles of sequencing,31 it could be
argued that further test adjustment, such that the wrist is moved
into dorsal extension first, would increase the likelihood of a
positive neurodynamic test in patients with CTS. A recent cadaver
study has however demonstrated that changing the order of
movement during neurodynamic testing does not affect the extent
of strain of the median nerve at the distal forearm.32
In accordance with previous studies,16,33-35 patients with CTS
had a somatosensory phenotype indicating loss of function
compared with participants without CTS. This was apparent for
both thermal and mechanical stimuli, which indicates a dysfunc-
tion affecting both the large and small fiber spectrum. Intriguingly,
the extent of loss of function was comparable between patients
with negative and positive neurodynamic tests apart from a more
pronounced deficit in warm detection in the negative ULNT
group. This seems counterintuitive because it suggests a more
severe nerve dysfunction of unmyelinated fibers in those with
negative neurodynamic tests. Small unmyelinated C fibers mediate
warm sensations,26 but a subgroup also has nociceptive function.
It has previously been shown that passive limb extension after
experimental nerve injury leads to an afferent barrage, including
the C fiber population.36 Recent studies suggest that entrapment
neuropathies can affect small fiber function34,37 and may even lead
to their structural degeneration.16 Potentially, a more severe
dysfunction of these small fibers may result in their decreased
firing on neurodynamic testing. In addition, the small (mostly
unmyelinated) fiber population also innervates the epineurium as
nervi nervorum.38 It has previously been argued that neural
mechanosensitivity may in part be attributed to a hyperexcitability
of these intrinsic nociceptive afferents.39 It could be speculated
that a similar loss of small fiber function as identified in target
tissue may also affect the nervi nervorum, therefore leading to a
reduced response during neurodynamic testing.
Future studies will have to examine whether our findings of a
more pronounced dysfunction of the unmyelinated fibers in
patients with negative neurodynamic tests also applies to condi-
tions affecting the lower extremity. There is some indication that
the response to the straight leg raise is diminished in patients with
severe diabetic neuropathy.40 However, neuropathy severity was
based on vibration detection thresholds, which are mediated by
large myelinated fibers, and small fiber function was not exam-
ined. In our study, vibration detection was significantly impaired
in patients with negative ULNTs. It can however be debatedwhether the difference of 0.46 out of 8 on the tuning fork scale
is of clinical relevance.26 In addition, the opposing trend in
mechanical detection thresholds and comparable electrodiagnostic
test severity suggests that the function of the large fiber population
is not the predominant feature that differentiates patients with
CTS with and without positive neurodynamic tests.
Whereas we confirmed our hypothesis that patients with
negative neurodynamic tests are characterized by predominant
loss of function, our second hypothesis that positive neurodynamic
tests are associated with increased gain of function was not sub-
stantiated. In contrast with previous studies in patients with
CTS,41-44 our cohort was not characterized by gain of function in
any of the QST parameters. It has previously been shown that
patients with CTS have increased mechanosensitivity when
directly testing over the median nerve trunk,42 presumably
mediated by nervi nervorum.39 Future studies should include QST
over the nerve trunks to determine whether positive neurodynamic
tests are associated with elevated nerve trunk sensitivity rather
than its reflection in target tissues.
It could be argued that the slightly (albeit statistically insig-
nificant) higher proportion of men in the negative ULNT group
compared with the positive ULNT group (PZ.097) may have
influenced our findings, especially for pain thresholds, which are
affected by sex.26 Repeating the analysis with sex as a covariate
did however not change our results (data not shown). This together
with the comparability of the subgroups in regard to other de-
mographic, clinical, and psychological variables makes it unlikely
that our results are biased by confounding variables.Study limitations
The only parameter that differentiated the negative and positive
ULNT groups was a deficit in warm detection. Because the QST
battery involves 13 parameters, the likelihood of a false-positive
result increases. Each QST modality does however test highly
distinct fiber types (eg, thick myelinated vs thin myelinated vs
unmyelinated),26 which are not necessarily affected in the same
way in patients with entrapment neuropathies.14,16,35 It is therefore
commonly accepted that analysis of QST parameters does not
require correction for multiple testing.45 Future studies are how-
ever required to confirm our findings both in CTS and in other
peripheral neuropathies.www.archives-pmr.org
Neurodynamic tests and neural dysfunction 485Clinical implications
Because electrodiagnostic or imaging results are often not
available, practitioners commonly rely on clinical tests (eg,
neurodynamic or neurologic examination) when diagnosing
patients with suspected entrapment neuropathies. The presence of
a negative neurodynamic test is commonly interpreted as
diminishing the likelihood for neural involvement. Our findings
however suggest the opposite, namely that negative neuro-
dynamic tests may reflect the presence of a more pronounced
dysfunction, specifically of unmyelinated fibers. Recent studies
demonstrated that small fiber deficits may precede large fiber
dysfunction in patients with CTS.16,34 This together with our
results suggests that testing of small fibers is warranted before a
meaningful interpretation of neurodynamic tests is possible. Loss
of function of unmyelinated fibers is clinically identified using
the warm detection threshold.27 If quantitative thermal testing is
unavailable, clinicians may use cold and warm metallic objects to
identify potential differences in thermal thresholds.46,47 Future
studies are however needed to determine the validity of simple
but cost-effective bedside tests.Conclusions
A substantial proportion of patients with CTS have negative
neurodynamic tests despite a clear nerve involvement as deter-
mined with electrodiagnostic studies. Interestingly, patients with
negative neurodynamic tests were characterized by a more sub-
stantial loss of function in warm detection than patients with
positive neurodynamic test responses. This suggests a more pro-
nounced dysfunction of small unmyelinated fibers in patients with
negative neurodynamic tests. Therefore, when diagnosing neural
involvement clinically, neurodynamic test outcomes should not be
interpreted in isolation, but in the context of a sound clinical
reasoning specifically including neurologic integrity tests of the
small unmyelinated fiber population.Suppliers
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